Copyright Reports & Markets. All rights reserved.

Global Human Induced Pluripotent Stem Cells (iPSCs) Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Human Induced Pluripotent Stem Cells (iPSCs) by Type
    • 1.3.1 Overview: Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Consumption Value Market Share by Type in 2025
    • 1.3.3 Skin
    • 1.3.4 Blood
    • 1.3.5 Others
  • 1.4 Global Human Induced Pluripotent Stem Cells (iPSCs) Market by Application
    • 1.4.1 Overview: Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Academic Research
    • 1.4.3 Drug Development and Discovery
    • 1.4.4 Toxicity Screening
    • 1.4.5 Regenerative Medicine
    • 1.4.6 Others
  • 1.5 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size & Forecast
  • 1.6 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast by Region
    • 1.6.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region, (2021-2032)
    • 1.6.3 North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Prospect (2021-2032)
    • 1.6.6 South America Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 FUJIFILM Cellular Dynamics
    • 2.1.1 FUJIFILM Cellular Dynamics Details
    • 2.1.2 FUJIFILM Cellular Dynamics Major Business
    • 2.1.3 FUJIFILM Cellular Dynamics Human Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
    • 2.1.4 FUJIFILM Cellular Dynamics Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 FUJIFILM Cellular Dynamics Recent Developments and Future Plans
  • 2.2 Takara Bio
    • 2.2.1 Takara Bio Details
    • 2.2.2 Takara Bio Major Business
    • 2.2.3 Takara Bio Human Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
    • 2.2.4 Takara Bio Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Takara Bio Recent Developments and Future Plans
  • 2.3 Thermo Fisher Scientific
    • 2.3.1 Thermo Fisher Scientific Details
    • 2.3.2 Thermo Fisher Scientific Major Business
    • 2.3.3 Thermo Fisher Scientific Human Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
    • 2.3.4 Thermo Fisher Scientific Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.4 Ncardia
    • 2.4.1 Ncardia Details
    • 2.4.2 Ncardia Major Business
    • 2.4.3 Ncardia Human Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
    • 2.4.4 Ncardia Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Ncardia Recent Developments and Future Plans
  • 2.5 Sumitomo Dainippon Pharma
    • 2.5.1 Sumitomo Dainippon Pharma Details
    • 2.5.2 Sumitomo Dainippon Pharma Major Business
    • 2.5.3 Sumitomo Dainippon Pharma Human Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
    • 2.5.4 Sumitomo Dainippon Pharma Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Sumitomo Dainippon Pharma Recent Developments and Future Plans
  • 2.6 Astellas Pharma
    • 2.6.1 Astellas Pharma Details
    • 2.6.2 Astellas Pharma Major Business
    • 2.6.3 Astellas Pharma Human Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
    • 2.6.4 Astellas Pharma Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Astellas Pharma Recent Developments and Future Plans
  • 2.7 Fate Therapeutics
    • 2.7.1 Fate Therapeutics Details
    • 2.7.2 Fate Therapeutics Major Business
    • 2.7.3 Fate Therapeutics Human Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
    • 2.7.4 Fate Therapeutics Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Fate Therapeutics Recent Developments and Future Plans
  • 2.8 Cell Inspire Biotechnology
    • 2.8.1 Cell Inspire Biotechnology Details
    • 2.8.2 Cell Inspire Biotechnology Major Business
    • 2.8.3 Cell Inspire Biotechnology Human Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
    • 2.8.4 Cell Inspire Biotechnology Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Cell Inspire Biotechnology Recent Developments and Future Plans
  • 2.9 ReproCELL
    • 2.9.1 ReproCELL Details
    • 2.9.2 ReproCELL Major Business
    • 2.9.3 ReproCELL Human Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
    • 2.9.4 ReproCELL Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 ReproCELL Recent Developments and Future Plans
  • 2.10 AcceGen
    • 2.10.1 AcceGen Details
    • 2.10.2 AcceGen Major Business
    • 2.10.3 AcceGen Human Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
    • 2.10.4 AcceGen Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 AcceGen Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Human Induced Pluripotent Stem Cells (iPSCs) by Company Revenue
    • 3.2.2 Top 3 Human Induced Pluripotent Stem Cells (iPSCs) Players Market Share in 2025
    • 3.2.3 Top 6 Human Induced Pluripotent Stem Cells (iPSCs) Players Market Share in 2025
  • 3.3 Human Induced Pluripotent Stem Cells (iPSCs) Market: Overall Company Footprint Analysis
    • 3.3.1 Human Induced Pluripotent Stem Cells (iPSCs) Market: Region Footprint
    • 3.3.2 Human Induced Pluripotent Stem Cells (iPSCs) Market: Company Product Type Footprint
    • 3.3.3 Human Induced Pluripotent Stem Cells (iPSCs) Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Human Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Type (2021-2032)
  • 6.2 North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2032)
  • 6.3 North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
    • 6.3.1 North America Human Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Country (2021-2032)
    • 6.3.2 United States Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Human Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Type (2021-2032)
  • 7.2 Europe Human Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Application (2021-2032)
  • 7.3 Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
    • 7.3.1 Europe Human Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2021-2032)
    • 7.3.3 France Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region
    • 8.3.1 Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Region (2021-2032)
    • 8.3.2 China Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2021-2032)
    • 8.3.5 India Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Human Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Type (2021-2032)
  • 9.2 South America Human Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Application (2021-2032)
  • 9.3 South America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
    • 9.3.1 South America Human Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
    • 10.3.1 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Human Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Human Induced Pluripotent Stem Cells (iPSCs) Market Drivers
  • 11.2 Human Induced Pluripotent Stem Cells (iPSCs) Market Restraints
  • 11.3 Human Induced Pluripotent Stem Cells (iPSCs) Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Human Induced Pluripotent Stem Cells (iPSCs) Industry Chain
  • 12.2 Human Induced Pluripotent Stem Cells (iPSCs) Upstream Analysis
  • 12.3 Human Induced Pluripotent Stem Cells (iPSCs) Midstream Analysis
  • 12.4 Human Induced Pluripotent Stem Cells (iPSCs) Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Human Induced Pluripotent Stem Cells (iPSCs) market size was valued at US$ 160 million in 2025 and is forecast to a readjusted size of US$ 498 million by 2032 with a CAGR of 17.8% during review period.
    Induced pluripotent stem cells (iPSCs) are genetically reprogrammed adult cells that exhibit a pluripotent stem cell-like state similar to embryonic stem cells.1 While these artificially generated cells are not known to exist in the human body, they show qualities remarkably similar to those of embryonic stem cells (ESCs); thus, iPSCs are an invaluable resource for drug discovery, cell therapy, and basic research.
    This report is a detailed and comprehensive analysis for global Human Induced Pluripotent Stem Cells (iPSCs) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Human Induced Pluripotent Stem Cells (iPSCs) market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Human Induced Pluripotent Stem Cells (iPSCs) market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Human Induced Pluripotent Stem Cells (iPSCs) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Human Induced Pluripotent Stem Cells (iPSCs) market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Human Induced Pluripotent Stem Cells (iPSCs)
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Human Induced Pluripotent Stem Cells (iPSCs) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include FUJIFILM Cellular Dynamics, Takara Bio, Thermo Fisher Scientific, Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma, Fate Therapeutics, Cell Inspire Biotechnology, ReproCELL, AcceGen, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Human Induced Pluripotent Stem Cells (iPSCs) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Skin
    Blood
    Others
    Market segment by Application
    Academic Research
    Drug Development and Discovery
    Toxicity Screening
    Regenerative Medicine
    Others
    Market segment by players, this report covers
    FUJIFILM Cellular Dynamics
    Takara Bio
    Thermo Fisher Scientific
    Ncardia
    Sumitomo Dainippon Pharma
    Astellas Pharma
    Fate Therapeutics
    Cell Inspire Biotechnology
    ReproCELL
    AcceGen
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Human Induced Pluripotent Stem Cells (iPSCs) product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Human Induced Pluripotent Stem Cells (iPSCs), with revenue, gross margin, and global market share of Human Induced Pluripotent Stem Cells (iPSCs) from 2021 to 2026.
    Chapter 3, the Human Induced Pluripotent Stem Cells (iPSCs) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Human Induced Pluripotent Stem Cells (iPSCs) market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Human Induced Pluripotent Stem Cells (iPSCs).
    Chapter 13, to describe Human Induced Pluripotent Stem Cells (iPSCs) research findings and conclusion.

    Buy now